Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Merck KGaA to Acquire Bio-Techne Corporation

PRIVATESep 23, 2026about 2 hours ago

Acquiring Company

Merck KGaA Darmstadt Germany

Acquired Company

Bio-Techne Corporation

HesseMinneapolisManufacturingBiotechnologyHealth CareLife ScienceManufacturingBiotechnologyHealth CareScience And EngineeringBiotechnology Research

Description

On September 23, 2026, Bio-Techne Corporation held a special meeting to consider the merger agreement with Merck KGaA. The agreement allows Merck's subsidiary, EMD Holdings NewCo, Inc., to merge with Bio-Techne, making Bio-Techne a wholly-owned subsidiary of Merck. The transaction is set to expand Merck's presence in the life sciences sector.

Company Information

Company

Merck KGaA Darmstadt Germany

Location

Hesse, Germany

About

Merck KGaA is a leading science and technology company known for its innovative solutions in healthcare, life sciences, and performance materials. With a commitment to innovation and sustainability, it aims to improve the quality of life for patients globally. The company has a diverse portfolio and is focused on expanding its market presence. Merck KGaA is dedicated to strengthening its business sectors through strategic acquisitions.

Fundz sees it the moment Merck KGaA Darmstadt Germany makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nuno
Senior decision-maker at this company
••••••••@••••••••

See Nuno's verified email →

Celine
Senior decision-maker at this company
••••••••@••••••••

See Celine's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Merck KGaA Darmstadt Germany's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Bio-Techne Corporation?

Bio-Techne Corporation was acquired by Merck KGaA Darmstadt Germany, based in Hesse. The deal was reported on September 23, 2026. Merck KGaA is a leading science and technology company known for its innovative solutions in healthcare, life sciences, and performance materials. Merck KGaA Darmstadt Germany is privately held and operates in Manufacturing.

When did Merck KGaA Darmstadt Germany acquire Bio-Techne Corporation?

Merck KGaA Darmstadt Germany's acquisition of Bio-Techne Corporation was reported on September 23, 2026. On September 23, 2026, Bio-Techne Corporation held a special meeting to consider the merger agreement with Merck KGaA. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Bio-Techne Corporation do?

Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. It is publicly traded (TECH), operating in Manufacturing, and is based in Minneapolis.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.